Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
NXT Biomedical operates as a medical device/medtech incubator focused on developing and spinning out startups that address large unmet clinical needs. The company invests in intellectual property and supports the development of breakthrough technologies—primarily in cardiovascular medicine—to improve patient outcomes and reduce healthcare costs. It has filed at least 25 patents with a focus on cardiac conditions such as arrhythmias and congenital defects. The company was founded by Stanton Rowe, former Chief Scientific Officer of Edwards Lifesciences.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on NXT Biomedical.